VTVT (vTv Therapeutics) Earnings per share for the last four quarters

vTv Therapeutics Inc (VTVT) - corporate logo

vTv Therapeutics Inc. (VTVT) automates the creation of anti-diabetes molecules via biocomputer algorithms, operating in a promising market with a colossal patient base where growth is constrained only by strict regulatory standards. This chart of shares on GURU.Markets demonstrates an EPS TTM of 81.40. The application of AI and robotics accelerates pill synthesis, although final drug trials still require medical supervision.

VTVT vtvtherapeutics.com Net earnings per share (EPS TTM) (02/11/2024 - 11/18/2026)

VTVT (vtvtherapeutics.com): analytical breakdowns and indicator data

- business market valuation indicators:
Fundamental company valuation:VTVT (vTv Therapeutics Inc)
Core merchandise of vTv Therapeutics Inc.

The development dynamics of innovative drugs by vTv Therapeutics Inc. (VTVT) for the treatment of type 1 diabetes are reflected in the current EPS YoY TTM growth rate. This indicator measures the annual change in net income per share over a rolling twelve-month period, where daily recalculations eliminate reporting time lags, allowing investors to promptly assess capital resilience against market downturns.

Competitor analysis

Net earnings per one share for the last twelve months Ascendis Pharma Inc.|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Therapeutics|Net earnings per share (EPS TTM) MTSR|Earnings per share for the last twelve months MLTX (MoonLake Immunotherapeutics AG)|Earnings per share for the last twelve months crinetics.com CRNX|NewAmsterdam Pharma Corp (NAMS) - Net earnings per one share for the last twelve months|SLNO - Earnings per share for the last twelve months|FOLD: Earnings per share for the last twelve months|ETNB: Net earnings per share (EPS TTM)|AGIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Structure Corp|MiMedx Corp (MDXG) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months rezolutebio.com (RZLT)|Net earnings per share for the last 12 months lexpharma.com LXRX|Net earnings per share (EPS TTM) MBX (MBX Biosciences)|Altimmune Corp - Earnings per share for the last twelve months|Aardvark Therapeutics Inc. - Net earnings per share (EPS TTM)|SGMT - Net earnings per share (EPS TTM)|BioAge Labs (BIOA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months biomeafusion.com (BMEA)|Earnings per share for the last twelve months Quince Therapeutics, Inc.|Net earnings per share for the last 12 months Fractyl (GUTS)|Net earnings per share (EPS TTM) ATPC|Net earnings per share for the last four quarters Pluri Inc|Net earnings per share (EPS TTM) SYBX (Synlogic Corp)|Net earnings per share for the last four quarters lipocine.com (LPCN)|MTNB - Earnings per share for the last twelve months|Earnings per share for the trailing year SPRB (Spruce Biosciences)|GLTO (Galecto Corp) - Net earnings per share for the last 12 months|Carmell Corp - Earnings per share for the trailing year|LUMO (Lumos Therapeutics) - Net earnings per share (EPS TTM)|ONVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) RDUS